Fund Holdings — Ishara Investments LP

Total Portfolio Value:
$119.50M
Total Bought:
$119.50M
Total Sold:
$0
Net Transaction:
+$119.50M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Travere Therapeutics, Inc.(TVTX)0145,000+145,000$0$8.54M7.14%+$8.54M
Cytokinetics, Incorporated(CYTK)0128,000+128,000$0$8.44M7.06%+$8.44M
BridgeBio Pharma, Inc.(BBIO)0100,000+100,000$0$6.58M5.51%+$6.58M
Acadia Pharmaceuticals Inc0320,000+320,000$0$6.45M5.40%+$6.45M
Tarsus Pharmaceuticals, Inc.(TARS)070,000+70,000$0$5.50M4.60%+$5.50M
PTC Therapeutics, Inc.(PTCT)080,000+80,000$0$5.18M4.34%+$5.18M
Praxis Precision Medicines, Inc.(PRAX)017,000+17,000$0$4.95M4.14%+$4.95M
Vera Therapeutics, Inc.CL A(VERA)0150,000+150,000$0$4.84M4.05%+$4.84M
Arcutis Biotherapeutics, Inc.(ARQT)0180,000+180,000$0$4.76M3.98%+$4.76M
Annexon Inc01,120,000+1,120,000$0$4.74M3.96%+$4.74M
United Therapeutics Corporation(UTHR)08,000+8,000$0$4.34M3.63%+$4.34M
NewAmsterdam Pharma Company N.V.(NAMS)0160,000+160,000$0$3.89M3.26%+$3.89M
Xeris Biopharma Holdings Inc0400,000+400,000$0$3.82M3.20%+$3.82M
Celcuity Inc.(CELC)048,000+48,000$0$3.82M3.19%+$3.82M
Dbv Technologies S AADS0270,000+270,000$0$3.18M2.66%+$3.18M
Viridian Therapeutics, Inc.(VRDN)0150,000+150,000$0$3.09M2.58%+$3.09M
Zentalis Pharmaceuticals Inc01,080,000+1,080,000$0$2.99M2.50%+$2.99M
BioMarin Pharmaceutical Inc.(BMRN)048,000+48,000$0$2.88M2.41%+$2.88M
Biogen Inc.(BIIB)012,000+12,000$0$2.71M2.27%+$2.71M
Mineralys Therapeutics, Inc.(MLYS)0100,000+100,000$0$2.51M2.10%+$2.51M
Ligand Pharmaceuticals Incorporated(LGND)08,000+8,000$0$2.50M2.09%+$2.50M
Ultragenyx Pharmaceutical Inc.(RARE)0160,000+160,000$0$2.40M2.01%+$2.40M
Vaxcyte, Inc.(PCVX)040,000+40,000$0$2.28M1.90%+$2.28M
Oric Pharmaceuticals Inc0160,000+160,000$0$2.16M1.80%+$2.16M
Axsome Therapeutics, Inc.(AXSM)010,000+10,000$0$1.84M1.54%+$1.84M
Silence Therapeutics plcADS(SLN)0160,000+160,000$0$1.75M1.46%+$1.75M
Beam Therapeutics Inc.(BEAM)070,000+70,000$0$1.71M1.43%+$1.71M
Biohaven Ltd.(BHVN)0120,000+120,000$0$1.60M1.34%+$1.60M
Contineum Therapeutics IncCL A0108,000+108,000$0$1.45M1.21%+$1.45M
Genmab A/SADS(GMAB)040,000+40,000$0$1.43M1.19%+$1.43M
Neurocrine Biosciences, Inc.(NBIX)08,000+8,000$0$1.13M0.95%+$1.13M
Monopar Therapeutics Inc012,000+12,000$0$956.0K0.80%+$956.0K
MoonLake ImmunotherapeuticsCL A(MLTX)080,000+80,000$0$936.0K0.78%+$936.0K
Ars Pharmaceuticals Inc0200,000+200,000$0$862.0K0.72%+$862.0K
Ionis Pharmaceuticals, Inc.(IONS)016,000+16,000$0$714.4K0.60%+$714.4K
Olema Pharmaceuticals Inc080,000+80,000$0$691.2K0.58%+$691.2K
Lexicon Pharmaceuticals Inc0320,000+320,000$0$600.0K0.50%+$600.0K
Wave Life Sciences IncSHS0160,000+160,000$0$592.0K0.50%+$592.0K
Savara Inc.(SVRA)080,000+80,000$0$412.8K0.35%+$412.8K
Gossamer Bio Inc024,000+24,000$0$284.4K0.24%+$284.4K
Page 1 of 1